{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:08:44Z","timestamp":1774472924324,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,4]]},"DOI":"10.1093\/nar\/gkx911","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T23:12:41Z","timestamp":1506553961000},"page":"D994-D1002","source":"Crossref","is-referenced-by-count":153,"title":["PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies"],"prefix":"10.1093","volume":"46","author":[{"given":"Petr","family":"Smirnov","sequence":"first","affiliation":[]},{"given":"Victor","family":"Kofia","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Maru","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Freeman","sequence":"additional","affiliation":[]},{"given":"Chantal","family":"Ho","sequence":"additional","affiliation":[]},{"given":"Nehme","family":"El-Hachem","sequence":"additional","affiliation":[]},{"given":"George-Alexandru","family":"Adam","sequence":"additional","affiliation":[]},{"given":"Wail","family":"Ba-alawi","sequence":"additional","affiliation":[]},{"given":"Zhaleh","family":"Safikhani","sequence":"additional","affiliation":[]},{"given":"Benjamin","family":"Haibe-Kains","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"key\n\t\t\t\t20180103190745_B1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Global Burden of Disease Cancer Collaboration","year":"2017","journal-title":"JAMA Oncol."},{"key":"key\n\t\t\t\t20180103190745_B2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin","volume":"158","year":"2014","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180103190745_B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrc1739","article-title":"Biomarkers in cancer staging, prognosis and treatment selection","volume":"5","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180103190745_B4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2013.49.4799","article-title":"Precision oncology: an overview","volume":"31","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20180103190745_B5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrc2820","article-title":"Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents","volume":"10","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180103190745_B6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact of high-throughput screening in biomedical research","volume":"10","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20180103190745_B7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B9","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/gb-2013-14-10-r110","article-title":"Modeling precision treatment of breast cancer","volume":"14","year":"2013","journal-title":"Genome Biol."},{"key":"key\n\t\t\t\t20180103190745_B10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20180103190745_B11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature17987","article-title":"Reproducible pharmacogenomic profiling of cancer cell line panels","volume":"533","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B12","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature20171","article-title":"Consistency in drug response profiling","volume":"540","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B13","article-title":"A landscape of pharmacogenomic interactions in cancer","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180103190745_B14","article-title":"Enhancing reproducibility in cancer drug screening: how do we move forward?","year":"2014","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20180103190745_B15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature17987","article-title":"Reproducible pharmacogenomic profiling of cancer cell line panels","volume":"533","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature15736","article-title":"Pharmacogenomic agreement between two cancer cell line data sets","volume":"528","author":"Cancer Cell Line Encyclopedia Consortium and Genomics of Drug Sensitivity in Cancer Consortium","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103190745_B17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.12688\/f1000research.8705.1","article-title":"Assessment of pharmacogenomic agreement","volume":"5","year":"2016","journal-title":"F1000Res."},{"key":"key\n\t\t\t\t20180103190745_B18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.12688\/f1000research.9611.1","article-title":"Revisiting inconsistency in large pharmacogenomic studies","volume":"5","year":"2016","journal-title":"F1000Res."},{"key":"key\n\t\t\t\t20180103190745_B19","article-title":"PharmacoGx: an R package for analysis of large pharmacogenomic datasets","year":"2016","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103190745_B20","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","year":"2015","journal-title":"Cancer Discov."},{"key":"key\n\t\t\t\t20180103190745_B21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","year":"2013","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180103190745_B22","first-page":"2724","article-title":"Subtype and pathway specific responses to anticancer compounds in breast cancer","volume":"109","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20180103190745_B23","article-title":"ExPASy - Cellosaurus","year":"2015","journal-title":"Cellosaurus"},{"key":"key\n\t\t\t\t20180103190745_B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: a next-generation drug library and information resource","volume":"23","year":"2017","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20180103190745_B25","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103190745_B26","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103190745_B27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/nar\/gkg050","article-title":"Human gene-centric databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE","volume":"31","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103190745_B28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","article-title":"GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support","volume":"14","year":"1998","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103190745_B29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20180103190745_B30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/tpj.2015.32","article-title":"PGMD: a comprehensive manually curated pharmacogenomic database","volume":"16","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"key\n\t\t\t\t20180103190745_B31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000365895","article-title":"DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics","volume":"17","year":"2014","journal-title":"Public Health Genomics"},{"key":"key\n\t\t\t\t20180103190745_B32","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies","volume":"4","year":"2014","journal-title":"Sci. Rep."},{"key":"key\n\t\t\t\t20180103190745_B33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"key\n\t\t\t\t20180103190745_B34","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/0008-5472.CAN-17-0096","article-title":"Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy","volume":"77","year":"2017","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20180103190745_B35","first-page":"521","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"6","year":"2016","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t20180103190745_B36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt.3882","article-title":"Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics","volume":"35","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20180103190745_B37","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20180103190745_B38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1289\/ehp.1409157","article-title":"Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms","volume":"124","year":"2016","journal-title":"Environ. Health Perspect."},{"key":"key\n\t\t\t\t20180103190745_B39","doi-asserted-by":"crossref","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103190745_B40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/14622416.7.7.1025","article-title":"Toxicogenomics in drug discovery and development: mechanistic analysis of compound\/class-dependent effects using the DrugMatrix database","volume":"7","year":"2006","journal-title":"Pharmacogenomics"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/D1\/D994\/23162705\/gkx911.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T08:48:50Z","timestamp":1693039730000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/46\/D1\/D994\/4372597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":40,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2017,10,9]]},"published-print":{"date-parts":[[2018,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkx911","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/195149","asserted-by":"object"}]},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,4]]},"published":{"date-parts":[[2017,10,9]]}}}